TY - JOUR
T1 - A multi-centre international study of salivary hormone oestradiol and progesterone measurements in ART monitoring
AU - Sakkas, Denny
AU - Howles, Colin M.
AU - Atkinson, Leslie
AU - Borini, Andrea
AU - Bosch, Ernesto A.
AU - Bryce, Crystal
AU - Cattoli, Monica
AU - Copperman, Alan B.
AU - de Bantel, Astrid Finet
AU - French, Brian
AU - Gerris, Jan
AU - Granger, Steve W.
AU - Grzegorczyk-Martin, Veronika
AU - Lee, Joseph A.
AU - Levy, Michael J.
AU - Matin, Marla J.
AU - Somers, Sara
AU - Widra, Eric A.
AU - Alper, Michael M.
N1 - Publisher Copyright:
© 2020 Reproductive Healthcare Ltd.
PY - 2021/2
Y1 - 2021/2
N2 - Research question: Ovarian stimulation during IVF cycles involves close monitoring of oestradiol, progesterone and ultrasound measurements of follicle growth. In contrast to blood draws, sampling saliva is less invasive. Here, a blind validation is presented of a novel saliva-based oestradiol and progesterone assay carried out in samples collected in independent IVF clinics. Design: Concurrent serum and saliva samples were collected from 324 patients at six large independent IVF laboratories. Saliva samples were frozen and run blinded. A further 18 patients had samples collected more frequently around the time of HCG trigger. Saliva samples were analysed using an immunoassay developed with Salimetrics LLC. Results: In total, 652 pairs of saliva and serum oestradiol were evaluated, with correlation coefficients ranging from 0.68 to 0.91. In the European clinics, a further 237 of saliva and serum progesterone samples were evaluated; however, the correlations were generally poorer, ranging from –0.02 to 0.22. In the patients collected more frequently, five out of 18 patients (27.8%) showed an immediate decrease in oestradiol after trigger. When progesterone samples were assessed after trigger, eight out of 18 (44.4%) showed a continued rise. Conclusions: Salivary oestradiol hormone testing correlates well to serum-based assessment, whereas progesterone values, around the time of trigger, are not consistent from patient to patient.
AB - Research question: Ovarian stimulation during IVF cycles involves close monitoring of oestradiol, progesterone and ultrasound measurements of follicle growth. In contrast to blood draws, sampling saliva is less invasive. Here, a blind validation is presented of a novel saliva-based oestradiol and progesterone assay carried out in samples collected in independent IVF clinics. Design: Concurrent serum and saliva samples were collected from 324 patients at six large independent IVF laboratories. Saliva samples were frozen and run blinded. A further 18 patients had samples collected more frequently around the time of HCG trigger. Saliva samples were analysed using an immunoassay developed with Salimetrics LLC. Results: In total, 652 pairs of saliva and serum oestradiol were evaluated, with correlation coefficients ranging from 0.68 to 0.91. In the European clinics, a further 237 of saliva and serum progesterone samples were evaluated; however, the correlations were generally poorer, ranging from –0.02 to 0.22. In the patients collected more frequently, five out of 18 patients (27.8%) showed an immediate decrease in oestradiol after trigger. When progesterone samples were assessed after trigger, eight out of 18 (44.4%) showed a continued rise. Conclusions: Salivary oestradiol hormone testing correlates well to serum-based assessment, whereas progesterone values, around the time of trigger, are not consistent from patient to patient.
KW - Luteal support
KW - Ovarian stimulation monitoring
KW - Saliva estradiol
KW - Saliva progesterone
UR - http://www.scopus.com/inward/record.url?scp=85097078355&partnerID=8YFLogxK
U2 - 10.1016/j.rbmo.2020.10.012
DO - 10.1016/j.rbmo.2020.10.012
M3 - Article
C2 - 33279419
AN - SCOPUS:85097078355
SN - 1472-6483
VL - 42
SP - 421
EP - 428
JO - Reproductive BioMedicine Online
JF - Reproductive BioMedicine Online
IS - 2
ER -